NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 130 / 982

  1. Prevalence of Sexualized Substance Use and Chemsex in the General Population and Among Women: A Systematic Review and Meta-Analysis of Cross-Sectional Studies2025 · OpenAlex
  2. Prevalence of Substance Use and Its Predictors among Malaysian School-Going Adolescents at Drug-Based Hotspot Areas2025 · Crossref
  3. Prevalence of Substance Use Disorder Among Autistic Youth With and Without Co‐Occurring Mental Health Conditions and a History of Trauma2025 · Crossref
  4. Prevalence of substance use disorder among patients hospitalized for heart failure2025 · Crossref
  5. Prevalence of substance use disorder in individuals with attention deficit/hyperactivity disorder: associations with sex and psychiatric comorbidity2025 · Crossref
  6. Prevalence of Tobacco Use and Successful Tobacco Quitting among Persons of Kageshwori-Manohara Municipality in Kathmandu, Nepal2025 · Crossref
  7. Prevalence of Various Substance Use Disorders Among Juvenile Delinquents Coming in Contact with Law Enforcement Agencies- A Cross-Sectional Study2025 · Crossref
  8. Prevalence Rates, Perceptions of Risk, and Motivations for Nonmedical Cannabis Use in Pediatric Pain2025 · Crossref
  9. Prevalence, clinical, and sociodemographic correlates of gambling disorder in alcohol use disorder patients: A cross-sectional study2025 · Crossref
  10. Prevalence, drug education, and other associated factors of current illicit drug use among a nationally representative sample of school-aged adolescents in the Philippines in 20192025 · Crossref
  11. Prevalence, patterns and determinants of tobacco and alcohol use among construction site workers in Dehradun, Uttarakhand2025 · Crossref
  12. Preventing Fentanyl-Related Overdose Deaths with Naloxone—A Medical Examiner Study2025 · Crossref
  13. Prevention and harm reduction of obesity (clinical prevention)2025 · Crossref
  14. Prevention of adolescent stimulant drug use: Do the home life environment and extracurricular activities influence this? Findings from the Irish Planet Youth Survey2025 · OpenAlex
  15. Prevention of Alcohol, Tobacco, and Illicit Drug Use Among Youth: A Scoping Review of European School-Based Programs with Insights on Mental Health2025 · Crossref
  16. Prevention of youth involvement in the use of narcotic drugs, psychotropic substances, or their analogues by members of organized criminal groups2025 · Crossref
  17. Primary, secondary and tertiary prevention of long-term benzodiazepine receptor agonists use in Belgium: a policy Delphi2025 · Crossref
  18. Princes+of+Protest%2C+Kings+of+Nonconformity2025 · OpenAlex
  19. Prior Authorization Requirements and Medicaid Enrollees’ Use of Tobacco Cessation Medications, Colorado, 20232025 · Crossref
  20. Prioritising people who use drugs in health policy: An Australian Capital Territory case study2025 · Crossref
  21. Prioritization of methods for assessing alcohol use in emergency room settings: findings from a qualitative study2025 · Crossref
  22. Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records2025 · Crossref
  23. Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies2025 · OpenAlex
  24. Proactive Text Messaging Outreach for Tobacco Cessation Among Patients With COPD Who Smoke: A Randomized Pilot2025 · Crossref
  25. Probing trends of opioid seizures and drug checking samples under a nascent “decriminalization” framework in Vancouver, Canada2025 · Crossref
  26. Probiotic hemp milk-market growth: An updated review2025 · OpenAlex
  27. Problem drinking and comorbidity with mental ill health: a cross-sectional study among healthcare workers in Sweden2025 · Crossref
  28. Problem substance use in young adults: The impact of adverse life experiences2025 · Crossref
  29. Problemas relacionados en lactantes con el mito de tomar alcohol para mayor producción de leche materna en madres primerizas de Chetumal, Quintana Roo2025 · Crossref
  30. Problematic Use of Video Games, Social Media, and Alcohol: Exploring Reciprocal Relations with the Big Five Personality Traits in a Longitudinal Design2025 · Crossref
  31. Problems of Women Workers of Betel Nut Processing Units in Jalpaiguri District, West Bengal2025 · Crossref
  32. Process Development for GMP-Grade Full Extract Cannabis Oil: Towards Standardized Medicinal Use2025 · OpenAlex
  33. Processes of development related with the implementation of the Icelandic prevention model in a rural Canadian community2025 · OpenAlex
  34. Procurement Pathways of Illegal Substances in Germany: A Systematic Review with Implications for Prevention, Harm Reduction, and Drug Policy2025 · Crossref
  35. Product and trial design considerations on the path towards a vaccine to combat opioid overdose2025 · OpenAlex
  36. Product Quality Management System: Improvement of Quality Management (on the Example of the Сompany “Kava Milatskaya”, Moscow)2025 · Crossref
  37. Production of industrial hemp (Cannabis sativa) plant added PA66 nanofiber membranes by the electrospinning method: Investigation of water desalting performances2025 · Crossref
  38. Production, Mechanisms, and Therapeutic Strategies of Tryptophan Metabolites in CNS Diseases2025 · OpenAlex
  39. Produtos à base de Cannabis Sativa para uso veterinário: usos, regulamentação, desafios e perspectivas2025 · Crossref
  40. Professor Petr D. Shabanov: a celebrated leader in St. Petersburg pharmacology (on his 70th anniversary)2025 · Crossref
  41. Profiling of various dry Cannabis sativa from Aceh, Indonesia, based on cannabinoids spectroscopy characteristics2025 · Crossref
  42. Profiling the antitumor phytochemicals in Tirur betel leaf (Piper Betel L. Var Puthukodi) crude extract: An analytical study2025 · Crossref
  43. Profound Opioid and Medetomidine Withdrawal: A Case Series and Narrative Review of Available Literature2025 · OpenAlex
  44. Programmatic mapping and size estimation of people who inject drugs to plan targeted HIV prevention and harm reduction programs in iran, a nationwide study2025 · OpenAlex
  45. Progress in Research on the Mechanism of GABA in Improving Sleep2025 · OpenAlex
  46. Prohibition of Drinking Alcohol in Public: A Legal Analysis of Malaysian Law2025 · Crossref
  47. Projected alcohol demand in college students with heavy drinking2025 · Crossref
  48. Projection of Marginal Existence and Cultural Scenario: A Study of The Opium Clerk by Kunal Basu2025 · Crossref
  49. Prologue: An Introduction to the Substance Use and Misuse Edition of Psychoanalytic Inquiry2025 · OpenAlex
  50. Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report2025 · OpenAlex
  51. Prolonged hallucinogenic effects following Psilocybe cubensis ingestion: Case report2025 · OpenAlex
  52. Prolonged sedation and unconsciousness after intoxication with the novel semisynthetic cannabinoid hexahydrocannabioctyl (HHC-C8): Two case descriptions2025 · OpenAlex
  53. Promises and pitfalls of safer smoking supply distribution in the United States: a thematic analysis of open-ended survey questions from harm reduction organizations2025 · Crossref
  54. Promising high fidelity genetic markers for sexing Cannabis sativa seedlings2025 · Crossref
  55. Promoting Health Equity Among People With Opioid Use Disorder and Serious Mental Illness Through the Chronic Disease Self-Management Program2025 · Crossref
  56. Promoting pedagogical ‘safe supply’ in response to Canada’s toxic-drug-poisoning crisis: a commentary on substance use education in social work curricula and the ‘toxic’ nature of Canada’s current drug supply2025 · Crossref
  57. Promoting Sustained Real-Life Benefits of Virtual Reality–Based Interventions in People With Mental Health and Substance Use Disorders: Qualitative Study2025 · Crossref
  58. Promotion of recovery from Traumatic Brain Injury (TBI) by Granulocyte Colony-Stimulating Factor (G-CSF) treatment requires cannabinoid receptor type 2 activity2025 · Crossref
  59. Proportions and trends of global adolescent knowledge and attitudes toward tobacco smoking from 1999 to 20192025 · Crossref
  60. Proposed Model to Identify Drug Trafficking on Social Media2025 · Crossref
  61. Proposing Bromo-Epi-Androsterone (BEA) for Post-Traumatic Stress Disorder (PTSD)2025 · Crossref
  62. Proposition 215: De Facto Legalization of Pot and the Shortcomings of Direct Democracy2025 · OpenAlex
  63. Propranolol Administration During Morphine Addiction Attenuates Reinstatement of Drug-Aversive Memories Caused by Exposure to Stressful Stimuli2025 · Crossref
  64. Prosesi Mandi Pengantin dalam Pernikahan Adat Masyarakat Banjar di Kecamatan Betara2025 · Crossref
  65. Prospective cohort study of fentanyl test strip use and distribution in three states: the stay safe study protocol and implementation recommendations for researchers2025 · OpenAlex
  66. Protecting children from tobacco products in retail environments: A review of Australian tobacco control laws2025 · Crossref
  67. Protecting Patient Autonomy in Psychedelic-Assisted Psychotherapy: A Nursing Ethics Perspective2025 · OpenAlex
  68. Protection of the rights of drug addicts and the right to a fair trial: Practice of the European court of human rights2025 · Crossref
  69. Protes Massa Untuk Perubahan Kebijakan Opiumregie: Gerakan Anti Opium di Hindia Belanda, 1900-19402025 · Crossref
  70. Protocol Commentary for the SUCCESS (Successful Recruitment and Retention in a Randomized Controlled Trial of Pregnant Participants with Opioid Use Disorder) Study2025 · Crossref
  71. Protocol for the INSPIRE Study: A Training Package for the Intrapartum Team to Promote Respectful and Non-stigmatizing Care for Patients with Substance Use Disorder2025 · Crossref
  72. Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)2025 · OpenAlex
  73. PROTOCOL: Investigating the Intersection of Parenting and Substance Use Recovery Identities: A Qualitative Scoping Review2025 · Crossref
  74. Protonitazene metabolite variability in postmortem casework2025 · Crossref
  75. Proyecto ALCO-VR: Un ensayo clínico aleatorizado para la evaluación de la eficacia de la Terapia de Exposición a Señales con Realidad Virtual en pacientes resistentes al tratamiento diagnosticados con trastorno por uso de alcohol2025 · OpenAlex
  76. Práctica productiva ancestral. Una visión de producción de cannabis desde los sistemas dinámicos y adaptativos.2025 · Crossref
  77. Psicodélicos S. A.: reflexiones sobre la capitalización y el corporativismo de las plantas de poder2025 · OpenAlex
  78. Psicofármacos en Argentina (2003-2023). Caracterización y reflexiones sobre el mercado de las benzodiacepinas desde los estudios sociales del fármaco2025 · OpenAlex
  79. PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and Behaviour2025 · OpenAlex
  80. Psilocibina e LSD no tratamento da depressão: eficácia terapêutica, modulação neurobiológica e desafios clínicos2025 · Crossref
  81. Psilocibina en cuidados paliativos: revisión sistemática de los efectos a nivel emocional y espiritual-existenciales2025 · OpenAlex
  82. Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons2025 · OpenAlex
  83. Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ‐ and MES‐Induced Seizures in Mice via 5‐HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways2025 · OpenAlex
  84. Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de Argentina2025 · OpenAlex
  85. Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?2025 · PubMed
  86. Psilocybin and Death Anxiety: A Dual-Mechanism Approach to Existential Distress2025 · OpenAlex
  87. Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency2025 · Crossref
  88. Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological and Clinical Approach2025 · OpenAlex
  89. Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.2025 · PubMed
  90. Psilocybin biosynthesis enhancement through gene source optimization.2025 · PubMed
  91. Psilocybin Dispensaries and Online Health Claims in Canada2025 · Crossref
  92. Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring2025 · OpenAlex
  93. Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice.2025 · PubMed
  94. Psilocybin Experiential Therapist Training: Insights from a World-First Study2025 · OpenAlex
  95. Psilocybin for disorders of consciousness: A case-report study2025 · OpenAlex
  96. Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain models2025 · OpenAlex
  97. Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial2025 · OpenAlex
  98. Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review2025 · OpenAlex
  99. Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials2025 · OpenAlex
  100. Psilocybin induces sex- and context-specific recruitment of the stress axis2025 · OpenAlex